W. Li, M. Shi / Tetrahedron 65 (2009) 6815–6821
6819
525 cmꢁ1. MS (%) m/e 552 (Mþ, 0.3), 383 (0.3), 335 (100), 302 (2.0),
287 (2.4), 261 (1.4), 251 (1.9), 216 (0.9), 210 (1.6). HRMS (EI) for
C35H37S2P: 552.2074. Found: 552.2076.
7.05–7.15 (m, 6H, Ar), 7.34–7.38 (m, 5H, Ar), 7.72 (dd, J¼7.5, 13.5 Hz,
2H, Ar), 7.91 (dd, J¼7.2, 14.4 Hz, 2H, Ar). 13C NMR (CDCl3, 100 MHz,
TMS)
d
19.2, 19.6 (d, JC–P¼14.4 Hz), 21.3, 22.6, 27.9, 30.4 (d, JC–P¼
7.2 Hz), 31.6, 41.6 (d, JC–P¼4.1 Hz), 55.2, 112.7, 126.8, 127.4, 127.7 (d,
4.2.3. 1-(2,2-Bis(4-methoxyphenyl)vinyl)-2,2,3,3-
JC–P¼13.3 Hz), 128.3, 128.4, 128.7 (d, JC–P¼1.9 Hz), 130.7 (d, JC–P¼
tetramethylcyclopropyl diphenylphosphinodithioate 2c
11.1 Hz), 131.0, 131.3, 131.6, 131.9 (d, JC–P¼11.1 Hz), 133.0, 134.1 (d, JC–
A white solid, Mp: 138–140 ꢀC; 1H NMR (CDCl3, 300 MHz, TMS)
¼84.0 Hz), 136.3 (d, JC–P¼85.6 Hz), 143.1, 143.6, 158.6. 31P NMR
P
d
0.41 (s, 3H, CH3), 1.08 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.48 (s, 3H,
(CDCl3, 121.45 MHz, 85% H3PO4) d 55.2. IR (CH2Cl2) n 3056, 2999,
CH3), 3.77 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 6.02 (s, 1H, CH), 6.64 (d,
J¼6.9 Hz, 2H, Ar), 6.76–6.83 (m, 4H, Ar), 7.06–7.10 (m, 3H, Ar), 7.34–
7.37 (m, 5H, Ar), 7.73 (dd, J¼6.6, 13.8 Hz, 2H, Ar), 7.92 (dd, J¼6.6,
2917, 2867, 2835, 1606, 1510, 1437, 1374, 1295, 1248, 1178, 1096,
1034, 908, 839, 718, 690, 655, 641, 606, 526 cmꢁ1. MS (%) m/e 554
(Mþ, 2), 337 (100), 304 (36), 289 (52), 263 (41), 253 (57), 217 (31),
165 (17), 139 (20). HRMS (EI) for C34H35S2OP: 554.1867. Found:
554.1864.
14.4 Hz, 2H, Ar). 13C NMR (CDCl3, 75 MHz, TMS)
d
19.2, 19.6 (d, JC–P
¼
12.8 Hz), 21.3, 27.8, 30.3 (d, JC–P¼6.2 Hz), 41.7 (d, JC–P¼3.1 Hz), 55.1,
55.2, 112.6, 112.7, 127.3, 127.5 (d, JC–P¼13.1 Hz), 128.3 (d, JC–P
¼
12.8 Hz), 129.3, 130.6, 130.7, 131.3, 131.6, 131.9 (d, JC–P¼10.7 Hz),
133.2, 134.1 (d, JC–P¼83.7 Hz), 136.26, 136.30 (d, JC–P¼84.8 Hz),
4.2.7. (Z or E)-5-(4-Methoxyphenyl)-2-methyl-5-phenyl-3-
(propan-2-ylidene)pent-4-en-2-yl diphenylphosphinodithioate 2f0
A white solid, Mp: 105–107 ꢀC; 1H NMR (CDCl3, 400 MHz, TMS)
142.4, 158.6, 158.7. 31P NMR (CDCl3, 121.45 MHz, 85% H3PO4)
d 59.9.
IR (CH2Cl2)
n
3055, 2998, 2916, 2835, 1606, 1510, 1437, 1289, 1246,
d 0.36 (s, 3H, CH3), 1.06 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.48 (s, 3H,
1174, 1096, 1035, 834, 717, 690, 655, 526 cmꢁ1. MS (%) m/e 367
(MþꢁPh2PS, 58), 334 (84), 319 (100), 293 (21), 278 (28), 250 (27),
217 (49), 121 (48), 43 (45). HRMS (EI) for C35H37S2O2P: 584.1973.
Found: 584.1984.
CH3), 3.79 (s, 3H, OCH3), 6.12 (s, 1H, CH), 6.66 (d, J¼9.2 Hz, 2H, Ar),
6.80 (d, J¼9.2 Hz, 2H, Ar), 7.07–7.11 (m, 3H, Ar), 7.25–7.27 (m, 3H,
Ar), 7.38–7.43 (m, 5H, Ar), 7.73 (dd, J¼7.5, 13.5 Hz, 2H, Ar), 7.92 (dd,
J¼7.2, 13.8 Hz, 2H, Ar). 13C NMR (CDCl3, 100 MHz, TMS)
d 19.3, 19.7
(d, JC–P¼20.9 Hz), 21.3, 27.8, 30.4 (d, JC–P¼7.2 Hz), 41.6 (d, JC–P
¼
4.2.4. 1-(2,2-Bis(4-chlorophenyl)vinyl)-2,2,3,3-
3.3 Hz), 55.2, 112.8, 127.0, 127.3, 127.8 (d, JC–P¼13.5 Hz), 128.3, 128.4,
129.3, 130.4, 130.7 (d, JC–P¼12.0 Hz), 131.3, 131.9 (d, JC–P¼10.3 Hz),
134.2 (d, JC–P¼84.8 Hz), 136.0, 136.3 (d, JC–P¼84.7 Hz), 140.8, 142.8,
tetramethylcyclopropyl diphenylphosphinodithioate 2d
A white solid, Mp: 191–193 ꢀC; 1H NMR (CDCl3, 300 MHz, TMS)
d
0.45 (s, 3H, CH3), 1.09 (s, 3H, CH3), 1.22 (s, 3H, CH3), 1.48 (s, 3H,
158.8. 31P NMR (CDCl3, 121.45 MHz, 85% H3PO4)
d 59.9. IR (CH2Cl2) n
CH3), 6.21 (s, 1H, CH), 6.76 (d, J¼8.7 Hz, 2H, Ar), 7.07–7.10 (m, 5H,
Ar), 7.22–7.30 (m, 4H, Ar), 7.36–7.38 (m, 3H, Ar), 7.71 (dd, J¼6.9,
13.2 Hz, 2H, Ar), 7.88 (dd, J¼6.9, 13.5 Hz, 2H, Ar). 13C NMR (CDCl3,
3056, 2999, 2918, 2867, 2835, 1714, 1605, 1509, 1437, 1246, 1096,
1035, 826, 718, 690, 647, 615 cmꢁ1. MS (%) m/e 554 (Mþ, 2), 337
(100), 304 (14), 289 (19), 263 (35), 253 (51), 217 (24), 165 (9), 121
(12). HRMS (EI) for C34H35S2OP: 554.1867. Found: 554.1863.
75 MHz, TMS)
d
19.3, 19.7 (d, JC–P¼19.7 Hz), 21.2, 28.0, 30.6 (d, JC–P
¼
5.7 Hz), 41.0 (d, JC–P¼3.2 Hz), 127.70, 127.74, 127.9, 128.4 (d, JC–P
¼
13.2 Hz), 129.3, 130.7 (d, JC–P¼10.4 Hz), 130.9, 131.0, 131.1, 131.6,
4.2.8. 1-(2-(4-Chlorophenyl)-2-phenylvinyl)-2,2,3,3-
tetramethylcyclopropyl diphenylphosphinodithioate 2g
The ratio of E/Z¼1:1. A light yellow solid, Mp: 98–100 ꢀC; 1H
131.9 (d, JC–P¼10.9 Hz), 133.0 (d, JC–P¼20.6 Hz), 134.1 (d, JC–P
¼
84.7 Hz), 136.1 (d, JC–P¼85.4 Hz), 138.5, 141.0, 141.4. 31P NMR (CDCl3,
121.45 MHz, 85% H3PO4)
d
60.0. IR (CH2Cl2)
n
3055, 2998, 2918,
NMR (CDCl3, 300 MHz, TMS) d 0.36 (s, 1.6H, CH3), 0.45 (s, 1.4H, CH3),
2859, 1716, 1491, 1436, 1375, 1217, 1093, 1014, 833, 719, 689, 653,
518 cmꢁ1. MS (%) m/e 592 (Mþ, 7), 518 (6), 375 (100), 327 (31), 291
(80), 217 (60), 155 (33), 139 (66), 125 (27). HRMS (EI) for
C33H31S2PCl2: 592.0982. Found: 592.0980.
1.06–1.09 (m, 3H, CH3),1.21–1.25 (m, 3H, CH3),1.48 (s, 3H, CH3), 6.18
(s, 0.5H, CH), 6.21 (s, 0.5H, CH), 6.77–6.85 (m, 2H, Ar), 7.06–7.17 (m,
4H, Ar), 7.23–7.40 (m, 9H, Ar), 7.68–7.75 (m, 2H, Ar), 7.84–7.95 (m,
2H, Ar). 31P NMR (CDCl3, 121.45 MHz, 85% H3PO4)
d
55.15, 55.21. IR
(CH2Cl2)
n 3056, 2998, 2945, 2918, 2867, 1980, 1592, 1487, 1437,
4.2.5. 1-(2,2-Bis(4-fluorophenyl)vinyl)-2,2,3,3-
1375, 1306, 1185, 1095, 1014, 908, 822, 733, 719, 690, 654, 525 cmꢁ1
.
tetramethylcyclopropyl diphenylphosphinodithioate 2e
MS (%) m/e 558 (Mþ, 4), 356 (8), 341 (100), 308 (45), 293 (60), 257
(87), 217 (57), 165 (34), 139 (39). HRMS (EI) for C33H32S2PCl:
558.1372. Found: 558.1366.
A white solid, Mp: 165–167 ꢀC; 1H NMR (CDCl3, 300 MHz, TMS)
d
0.40 (s, 3H, CH3),1.08 (s, 3H, CH3),1.22 (s, 3H, CH3),1.49 (s, 3H, CH3),
6.14 (s, 1H, CH), 6.80 (d, J¼6.6 Hz, 4H, Ar), 6.94–7.00 (m, 2H, Ar), 7.12
(br s, 3H, Ar), 7.33–7.38 (m, 5H, Ar), 7.71 (dd, J¼7.2, 13.8 Hz, 2H, Ar),
7.91 (dd, J¼7.2, 13.8 Hz, 2H, Ar). 13C NMR (CDCl3, 75 MHz, TMS)
4.2.9. 1-(2-(4-Fluorophenyl)-2-phenylvinyl)-2,2,3,3-
tetramethylcyclopropyl diphenylphosphinodithioate 2h
d
19.2, 19.7 (d, JC–P¼17.3 Hz), 21.2, 27.9, 30.4 (d, JC–P¼6.0 Hz), 41.2 (d,
The ratio of E/Z¼1:1. A light yellow solid, Mp: 88–90 ꢀC; 1H NMR
JC–P¼3.5 Hz), 114.3 (d, JC–F¼21.2 Hz), 114.4 (d, JC–F¼21.4 Hz), 127.7 (d,
JC–P¼13.2 Hz), 128.4 (d, JC–P¼13.5 Hz), 129.6 (d, JC–F¼8.3 Hz), 129.8,
130.7 (d, JC–P¼11.0 Hz),131.0,131.5,131.8,131.9 (d, JC–P¼7.2 Hz),134.1
(d, JC–P¼84.5 Hz),136.1 (d, JC–P¼85.6 Hz),136.3 (d, JC–F¼3.1 Hz),139.2
(CDCl3, 400 MHz, TMS) d 0.35 (s,1.5H, CH3), 0.43 (s,1.5H, CH3), 1.06–
1.08 (m, 3H, CH3), 1.22–1.26 (m, 3H, CH3), 1.49 (s, 3H, CH3), 6.14 (s,
0.5H, CH), 6.19 (s, 0.5H, CH), 6.79–6.85 (m, 3H, Ar), 6.94–6.98 (m,
1H, Ar), 7.09–7.16 (m, 4H, Ar), 7.26–7.28 (m, 2H, Ar), 7.34–7.41 (m,
5H, Ar), 7.70–7.75 (m, 2H, Ar), 7.86–7.96 (m, 2H, Ar). 31P NMR
(d, JC–F¼2.9 Hz), 141.2, 161.9 (d, JC–F¼246.3 Hz), 162.1 (d, JC–F
¼
244.2 Hz). 31P NMR (CDCl3, 121.45 MHz, 85% H3PO4)
(CDCl3, 282 MHz, CFCl3)
d
55.1. 19F NMR
3055, 2999,
(CDCl3, 121.45 MHz, 85% H3PO4)
282 MHz, CFCl3)
2867, 1715, 1600, 1507, 1437, 1375, 1224, 1158, 1096, 845, 718, 690,
656, 525 cmꢁ1. MS (%) m/e 542 (Mþ, 5), 468 (2), 325 (100), 309 (18),
277 (29), 251 (49), 241 (81), 217 (26), 139 (32). HRMS (EI) for
C33H32S2PF: 542.1667. Found: 542.1674.
d
55.31, 55.34. 19F NMR (CDCl3,
3055, 2999, 2918,
d
ꢁ119.7, ꢁ121.2. IR (CH2Cl2)
n
d
ꢁ121.6, ꢁ120.1. IR (CH2Cl2)
n
2919, 2868, 1600, 1508, 1437, 1375, 1229, 1157, 1096, 1015, 910, 840,
718, 690, 656, 525 cmꢁ1. MS (%) m/e 560 (Mþ, 3), 486 (3), 343 (100),
269 (49), 259 (100), 217 (39), 183 (25), 139 (86), 109 (30). HRMS (EI)
for C33H31S2PF2: 560.1573. Found: 560.1571.
4.2.6. (E or Z)-1-(2-(4-Methoxyphenyl)-2-phenylvinyl)-2,2,3,3-
tetramethylcyclopropyl diphenylphosphinodithioate 2f
4.2.10. 1-(2-(3,4-Difluorophenyl)-2-phenylvinyl)-2,2,3,3-
tetramethylcyclopropyl diphenylphosphinodithioate 2i
The ratio of E/Z¼1:1. A light yellow solid, Mp: 109–111 ꢀC; 1H
A white solid, Mp: 111–1113 ꢀC; 1H NMR (CDCl3, 300 MHz, TMS)
d
0.41 (s, 3H, CH3), 1.09 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.49 (s, 3H,
NMR (CDCl3, 300 MHz, TMS) d 0.33 (s, 1.5H, CH3), 0.53 (s, 1.5H, CH3),
CH3), 3.82 (s, 3H, OCH3), 6.08 (s, 1H, CH), 6.81–6.85 (m, 4H, Ar),
1.06–1.14 (m, 3H, CH3), 1.21–1.25 (m, 3H, CH3), 1.49 (s, 3H, CH3), 6.16